SCHEMBL39361

SCHEMBL39361

CCCCCCCCCCCCC(CS)CC(c1cc(C(C)(C)C)c(O)cc1C)c1cc(C(C)(C)C)c(O)cc1C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.60
TP53 P04637 2/20 0.60
CYP2D6 P10635 1/20 0.60
CYP2C9 P11712 1/20 0.60
CYP2C19 P33261 1/20 0.60
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
HIF1A Q16665 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
GAA P10253 1/20 0.33
XBP1 P17861 1/20 0.33
ATM Q13315 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP1A2 P05177 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18544067 0.92 ALOX15 (0.59) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL5710085 0.85 ALOX15 (0.78) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL11577973 0.85 ALOX15 (0.78) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL30804627 0.85 ALOX15 (0.78) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL5086034 0.85 ALOX15 (0.78) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL6547730 0.84 ALOX15 (0.64) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL6548170 0.84 ALOX15 (0.64) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL9226764 0.81 ALOX15 (0.72) ALOX15TP53CYP2D6CYP2C9CYP2C19
SCHEMBL30403625 0.81 ALOX15 (0.72) ALOX15TP53CYP2D6CYP2C9CYP2C19
Undecane SCHEMBL28084006 0.81 ALOX15 (0.63) ALOX15TP53CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 382 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308638-A1 USE OF A STABILIZER COMPOSITION FOR STABILIZING POLYOLEFIN RECYCLATES, STABILIZER COMPOSITION, MASTER BATCH CONCENTRATE, PLASTIC COMPOSITION, MOLDING COMPOUND OR MOLDING, METHOD FOR STABILIZING A POLYOLEFIN RECYCLATE AND USE OF A PLASTIC COMPOSITION Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2024-01-24 EP claimed
EP-4301809-A1 USE OF A STABILIZER COMPOSITION FOR STABILIZING HALOGEN-FREE RECYCLED THERMOPLASTICS, STABILIZER COMPOSITION, MASTER BATCH OR CONCENTRATE, STABILIZED PLASTIC COMPOSITION, PROCESS FOR STABILIZING HALOGEN-FREE RECYCLED THERMOPLASTICS, AND USE OF COMPOSITIONS Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2024-01-10 EP claimed
WO-2022194672-A1 USE OF A STABILIZER COMPOSITION FOR STABILIZING POLYOLEFIN RECYCLATES, STABILIZER COMPOSITION, MASTER BATCH CONCENTRATE, PLASTIC COMPOSITION, MOLDING COMPOUND OR MOLDING, METHOD FOR STABILIZING A POLYOLEFIN RECYCLATE AND USE OF A PLASTIC COMPOSITION Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2022-09-22 WO claimed
WO-2022184596-A1 USE OF A STABILIZER COMPOSITION FOR STABILIZING HALOGEN-FREE RECYCLED THERMOPLASTICS, STABILIZER COMPOSITION, MASTER BATCH OR CONCENTRATE, STABILIZED PLASTIC COMPOSITION, PROCESS FOR STABILIZING HALOGEN-FREE RECYCLED THERMOPLASTICS, AND USE OF COMPOSITIONS Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2022-09-09 WO claimed
EP-4536463-B1 PROCESS TO PREPARE THERMOPLASTIC COMPOSITIONS COMPRISING FLUORINE FREE POLYMER PROCESSING AIDS NOVA CHEMICALS INTERNATIONAL SA (CH) 2026-05-13 EP disclosed
US-20260071126-A1 Polymerizable Liquid Crystal Material and Polymerized Liquid Crystal Film MERCK PATENT GMBH (DE) 2026-03-12 US disclosed
US-20260070275-A1 FLUOROPOLYMER FREE POLYMER PROCESSING AIDS NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2026-03-12 US disclosed
US-12570900-B2 Polymerisable compound, polymerisable LC material and polymer film MERCK PATENT GMBH (DE) 2026-03-10 US disclosed
US-12565617-B2 Polymerisable oligomeric liquid crystal, polymerisable medium and polymerised liquid crystal film MERCK PATENT GMBH (DE) 2026-03-03 US disclosed
EP-4692239-A2 BLOCK COPOLYMER POLYMER PROCESSING AIDS Nova Chemicals (International) S.A. (CH) 2026-02-11 EP disclosed
EP-3786216-B1 PROCESSING ADDITIVES AND USES OF SAME IN ROTATIONAL MOLDING CYTEC TECH CORP (US) 2026-02-11 EP disclosed
US-12540235-B2 Rotomolding composition NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2026-02-03 US disclosed
EP-0701890-A1 Melt extrusion process GENERAL ELECTRIC COMPANY (US) 1996-03-20 EP disclosed
EP-0702019-A1 Liquid neo-diol phosphites as polymer stabilizers GENERAL ELECTRIC COMPANY (US) 1996-03-20 EP disclosed
EP-0702018-A1 Amorphous neo-diol phosphite compositions GENERAL ELECTRIC COMPANY (US) 1996-03-20 EP disclosed
US-5500467-A PHOSPHITES, DISCOLORATION INHIBITION GENERAL ELECTRIC COMPANY (US) 1996-03-19 US disclosed
US-5464889-A Stabilization of thermoplastic resins GENERAL ELECTRIC COMPANY (US) 1995-11-07 US disclosed
US-5424348-A Enhanced hydrolytic stability, resistance to ultraviolet radiation yellowing GENERAL ELECTRIC COMPANY (US) 1995-06-13 US disclosed
EP-0635514-A1 Neo-diol phosphites as polymer stabilizers GENERAL ELECTRIC COMPANY (US) 1995-01-25 EP disclosed
EP-0635512-A1 Cyclic phosphites as polymer stabilizers GENERAL ELECTRIC COMPANY (US) 1995-01-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570900-B2 Polymerisable compound, polymerisable LC material and polymer film L3MBTL3, L3MBTL1, L3MBTL4 ALOX15 2261/4885TP53 963/4885CYP2D6 2058/4885
US-20260071126-A1 Polymerizable Liquid Crystal Material and Polymerized Liquid Crystal Film MLX, SCO2, VCL ALOX15 2042/4885TP53 1510/4885CYP2D6 2967/4885
US-20260070275-A1 FLUOROPOLYMER FREE POLYMER PROCESSING AIDS PFKP, LCP1, PIGK ALOX15 1851/4885TP53 3348/4885CYP2D6 4416/4885
US-12565617-B2 Polymerisable oligomeric liquid crystal, polymerisable medium and polymerised liquid crystal film NOD1, OSTC, MLX ALOX15 1446/4885TP53 2690/4885CYP2D6 3688/4885
US-12540235-B2 Rotomolding composition MRPS17, POLM, FGB ALOX15 2430/4885TP53 2288/4885CYP2D6 2884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.